Evidence map›Paper›PMID 32757478›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2020

APPEAL-2: A pan-European qualitative study to explore the burden of peanut-allergic children, teenagers and their caregivers.

Audrey DunnGalvin, Katy Gallop, Sarah Acaster, Frans Timmermans, Lynne Regent, Sabine Schnadt, Marcia Podestà, Angel Sánchez, Robert Ryan, Pascale Couratier and 6 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Predictors of psychosocial burden in parents of children with food allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 5 countries.

Audrey DunnGalvinUniversity College Cork, Cork, Ireland.ORCID 0000-0002-1540-3959
Katy GallopAcaster Lloyd Consulting, London, UK.
Sarah AcasterAcaster Lloyd Consulting, London, UK.
Frans TimmermansNederlands Anafylaxis Netwerk, Dordrecht, The Netherlands.
Lynne RegentThe Anaphylaxis Campaign, Farnborough, UK.
Sabine SchnadtDeutscher Allergie- und Asthmabund, Mönchengladbach, Germany.
Marcia PodestàFood Allergy Italia, Padua, Italy.
Angel SánchezAsociación Española de Personas con Alergia a Alimentos y Látex, Madrid, Spain.
Robert RyanAimmune Therapeutics, London, UK.ORCID 0000-0003-0827-3153
Pascale CouratierAssociation Française pour la Prévention des Allergies, Paris, France.
Mary FeeneySt Thomas' Hospital, London, UK.
Betina HjorthAstma-Allergi Danmark, Roskilde, Denmark.
Helen R FisherKing's College London, London, UK.
Katharina BlumchenDivision of Pneumology, Allergology and Cystic Fibrosis, Department of Children and Adolescent Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Andrea VeredaAimmune Therapeutics, London, UK.
Montserrat Fernández-RivasHospital Clínico San Carlos, IdISSC, Madrid, Spain.
Aimmune Therapeutics (United Kingdom) · GBLloyd's · GBAsociación Española de Urología · ESGoethe University Frankfurt · DEHospital Clínico San Carlos · ESKing's College London · GBRoskilde Sygehus · DKStädtische Kliniken Mönchengladbach · DESt Thomas' Hospital · GBUniversity College Cork · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAllergy to Peanuts ImPacting Emotions And Life (APPEAL-1) was a recent European multi-country questionnaire survey that highlighted the negative impacts of peanut allergy (PA) on quality of life. A follow-on qualitative study, APPEAL-2, further assessed the burden of PA and associated coping strategies through semi-structured interviews.

objectiveTo gain qualitative insight on the strategies used to cope with and manage PA and the impact of these strategies on the quality of life of children, teenagers and caregivers.

methodsThis cross-sectional qualitative study was conducted in eight European countries: the United Kingdom, France, Germany, Ireland, Spain, Italy, Denmark and the Netherlands. Semi-structured interviews were conducted with children (aged 8-12 years) and teenagers (aged 13-17 years) with self-/proxy-reported moderate or severe PA and with parents/caregivers of children or teenagers (aged 4-17 years) with moderate or severe PA. Data were analysed using thematic analysis; data saturation was assessed. Two conceptual models were developed to illustrate the impacts of PA and coping strategies used to manage them for (a) individuals with PA and (b) parents/caregivers of children with PA.

results107 participants were interviewed: 24 children, 39 teenagers and 44 caregivers. The conceptual models illustrated themes related to coping and control, driven by the fear of PA reactions, and the associated emotional, social, relationship and work impacts. Factors moderating these impacts included social attitudes and support, child-caregiver relationship and coping strategies used. CONCLUSIONS AND CLINICAL RELEVANCE: The APPEAL-2 results substantiate the findings of APPEAL-1; the results also suggest that the severity of experience with PA may not correlate with perception of its overall burden and show variable impacts by country.

Indexed as

Adaptation, PsychologicalAdolescent BehaviorChild BehaviorCost of IllnessQuality of LifeAdolescentAdultAge FactorsCaregiversChildChild, PreschoolCross-Sectional StudiesEmotionsEuropeFemaleHumansburdenconceptual modelsfood allergypaediatricspeanut allergyquality of life

Identifiers

PMID32757478
PMCPMC7780296
OpenAlexW3048361466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.